Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot #HCRN MEL17-309/NU G18M02: Phase II Single-Arm Multi-Center Study of Adjuvant Ipilimumab in Combination with Nivolumab in Subjects with High-Risk Ocular Melanoma
Chandra, Sunandana
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
10/22/19
→
10/22/22
Funding
Hoosier Cancer Research Network, Inc.
(Prot #HCRN MEL17-309/NU G18M02)
Bristol-Myers Squibb Company
(Prot #HCRN MEL17-309/NU G18M02)
View all
View less